Cytokines and other mediators whose induction in inflammatory lung disease is attenuated by glucocorticoids are potential targets for development of selective anti-inflammatory treatments.
INTRODUCTION
Inflammation is regulated, in part, by the anti-inflammatory actions of the adrenal glucocorticoid hormones. Even at physiological concentrations in unstressed animals, glucocorticoids exert an important restraining effect on inflammatory responses (40, 41) . Systemic stress causes increased secretion of glucocorticoids, which help to limit the injury potentially caused by uncontrolled activation of inflammatory mediators. Adrenalectomy sensitizes animals to the lethal effects of endotoxin, IL-1β, TNF-α, and viral infection, but increased glucocorticoid receptor gene dosage or pretreatment with glucocorticoids is protective (7, 38, 50, 53) . Because of their broad and powerful anti-inflammatory effects, glucocorticoids have remained important agents in the treatment of many inflammatory diseases, including asthma, for nearly a half century.
Inflammation is also thought to have important roles in the pathophysiologies of bronchopulmonary dysplasia (BPD) in neonates (14, 29, 60) , and of adult respiratory distress syndrome (ARDS) (11, 68, 70) . Demonstrable short-term improvements in respiratory function, sometimes dramatic, resulted in widespread use of postnatal glucocorticoids for attempted prevention or treatment of BPD during the past decade. Improvement in long-term outcome has not been demonstrated, however. Because of the potential for serious adverse effects, including neurodevelopmental impairment, the routine use of corticosteroids for prevention or treatment of BPD in preterm infants is no longer recommended (3, 4, 6, 20) . The results of using glucocorticoids for prevention or treatment of acute ARDS have also been disappointing (11, 68, 70) , though a large multi-center trial is currently evaluating the use of glucocorticoids in the late, fibrosing phase of ARDS. The limited effectiveness of glucocorticoids in BPD and ARDS may be due, in part, to adverse effects of glucocorticoids on lung growth and repair that negate the potential benefits of reduced lung inflammation. If specific sets of inflammatory mediators important in the pathophysiology of these diseases could be identified, it might be possible to develop selective antiinflammatory treatments that are safer and more effective.
One approach to finding new targets for anti-inflammatory treatments of lung diseases may be to identify lung-expressed genes whose activity is modulated by glucocorticoids. Although other mechanisms also contribute, a major part of the anti-inflammatory actions of glucocorticoids is LCMP- 00496-2001.R1, p. 4 attributed to their ability to attenuate the induction of genes encoding a variety of mediators important in inflammatory and immune responses (1, 5) . Glucocorticoids inhibit the induction of the inducible form of prostaglandin H synthetase (cyclooxygenase 2), the inducible form of nitric oxide synthetase, and numerous inflammatory cytokines and chemokines including IL-1, TNF-α, and IL-8 (1, 5, 58) . We refer to inflammatory stimulus-induced genes whose message expression is attenuated by glucocorticoids as glucocorticoid-attenuated response genes, or GARGs.
We previously suggested that there are many GARGs not yet described, and tested that hypothesis using a cell culture model (58) . Before that study, all of the known GARGs had been identified either via assays of their biological activity, or by procedures based on screening for inducibility. In each case, glucocorticoid attenuation was investigated after the gene or its product had been identified. In our study, differential hybridization screening of a Swiss 3T3 cell library identified twelve different LPS-inducible GARG cDNAs (58) . Five were previously undescribed murine sequences, including a new chemokine, LPS-Induced CXC chemokine, or LIX (58) . The high proportion of new sequences identified in that small-scale screening supported the hypothesis that many GARGs remained to be identified. We subsequently verified that endotoxemia-induced LIX expression was strongly glucocorticoid-attenuated in the lungs of adrenalectomized (ADX) mice (51) . In contrast, the related chemokines KC and MIP-2 were LPS-induced but not glucocorticoid-attenuated in the lungs of the ADX or normal mice, despite the ability of glucocorticoids to attenuate the induction of KC and MIP-2 induction in cell culture studies. These results emphasized the importance of in vivo studies for determining which genes are subject to attenuation by glucocorticoids in specific models of lung inflammation.
The goal of the present study was to identify GARGs induced in the lung during endotoxemia. We hoped to identify novel genes as well as genes not previously implicated in lung inflammation, as candidates for further study in other models. We also hoped to gain a better understanding of characteristics of the GARG class as a whole. An advantage of the endotoxemia model for this study is that intravenous injection of LPS triggers the prompt release of endogenous mediators including TNF-α, IL-1β, and IFN-γ, so downstream genes responsive to these mediators, as well as those directly responsive to LPS, are induced. Although the timing and pattern of gene expression will differ in specific disease models, many of the genes induced during endotoxemia are LCMP- 00496-2001.R1, p. 5 expected to participate in a wide variety of acute and chronic inflammatory lung diseases. ADX mice were used for the screening in order to eliminate the effects of endogenous glucocorticoids and maximize potential message attenuation in response to an exogenous steroid. The expression characteristics of candidate GARG cDNAs were evaluated in normal as well as ADX mice.
Anticipating that GARG messages would constitute only a small fraction of the total mRNA population in the lung, we used a two-stage screening strategy. First, a subtracted library enriched in endotoxemia-induced genes was constructed using lung RNA from ADX mice. The library was then screened by differential hybridization to select candidate GARG clones. Northern analysis confirmed glucocorticoid attenuation of endotoxemia-induced lung expression for 36 GARG cDNAs. The majority were genes of unknown function not previously implicated in the pulmonary response to inflammation. Four were new murine sequences, including the murine orthologue of the human I-TAC chemokine (CXCL11), as we reported previously (71) , and a new member of the guanylate binding protein (GBP) family, murine GBP-5. We report here the complete cDNA sequences of a new member of the 2´-5´ oligoadenylate synthetase-like family (murine OASL-2), and a novel Lung-Inducible Neuralized-related C3HC4 RING domain protein (LINCR) and its predicted human homologue. The results of this study indicate that the network of glucocorticoidattenuated genes participating in the lung response to endotoxemia is much more extensive and diverse than previously thought.
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METHODS
Animals
ADX, sham-operated, and non-operated male Swiss-Webster mice purchased from Charles River Laboratories (Cambridge, MA) were studied at 8-12 weeks of age, and at least 2 weeks after operation. Mice were housed under specific pathogen-free conditions in the UCLA Health Sciences
Center vivarium for at least 1 week before experimental manipulation. ADX mice were supplied with normal saline instead of water to drink. All procedures were performed in accordance with protocols approved by the UCLA animal care and use committee.
Sterile, tissue-culture certified LPS prepared by phenol extraction and gel filtration from E. coli serotype O111:B4 was obtained from Sigma (St. Louis, MO). Preservative-and pyrogen-free saline (Abbot Laboratories, North Chicago, IL) was used for dilution of LPS and for control injections. Dexamethasone sodium phosphate (4 mg/ml of dexamethasone phosphate equivalent) for injection was obtained from Elkins-Sinn (Cherry Hill, NJ). LPS (50 µg in 200 µL sterile saline) or saline alone was injected via the tail vein. Two 400 µg doses of dexamethasone in 100 µL saline, or saline alone, were injected s.c. 18-20 h before and 5 min before LPS. Lungs and other organs were harvested for RNA preparation as described (51) .
Construction of subtracted library
A cDNA population enriched in endotoxemia-induced messages was generated using the suppression subtraction hybridization (SSH) technique (17, 18) . Lung RNA for the "tester" population was prepared from ADX mice killed 1, 2, or 4 hours after tail vein injection of LPS (4-5 mice per group). Lung RNA for the "driver" population was prepared from ADX mice treated with two doses of Dex as above, and killed 1, 2, and 4 h after the second dose (4 mice per group). Poly-A selected RNAs were prepared from the pooled tester and pooled driver RNAs using the PolyATtract I kit (Promega, Madison, WI). After first and second strand synthesis, the tester and driver cDNAs were digested with Rsa I, and aliquots of the tester cDNA were separately ligated to the SSH adapters I and II from the PCR-Select cDNA Subtraction Kit (Clontech, Palo Alto, CA). Sequential 7 h and 16 h hybridizations of the driver with the adapted tester cDNAs and PCR amplification of the subtracted cDNAs were performed as described in the PCR-Select manual.
The PCR-amplified subtracted cDNAs had an Xma I site and an Eag I site at opposite ends of the cDNA insert, within adapter-derived sequences. The subtracted cDNAs were sequentially digested with Xma I and Eag I, and then ligated to EcoRI-SalI-XmaI and XhoI-NcoI-EagI adapters we designed. The EcoRI-SalI-XmaI adapter was prepared by annealing nonphosphorylated AATTCTCCAGCGTGTCGACT with 5´-phosphorylated CCGGAGTCGACACGCTGGAG. Nonphosphorylated TCGAGTGCTGTGTAGGTATCCAT and 5´-phosphorylated GGCCATGGATACCTACACAGCAC were annealed to generate the XhoI-NcoI-EagI adapter. After the ligation, excess adapters and short cDNAs were removed by passing the reaction mixture over Chromaspin-200 columns (Clontech) three times. The adapted cDNAs were then phosphorylated using T4 kinase (New England Biolabs), ligated to Eco RI-and Xho I-digested λ Zap II (Stratagene, La Jolla, CA), and packaged with Gigapack Gold III (Stratagene). The primary library, containing 4 x 10 5 phage (95% recombinants), was amplified once. The cDNA insert sizes of 18 randomly-selected phage ranged from 460-1230 nt (mean 630).
Phage screening and analysis
Diluted aliquots from the subtracted library were plated at a density of •950 plaques per 150 mm petri dish. One additional dish was plated with •200 plaques. Each plate was also inoculated at specific locations with plaque-pure control phage containing inserts of LIX, MCP-1, and ribosomal protein S2 (rpS2) cDNA. PolyA-selected RNA for the "LPS probe" was prepared from pooled lung RNA from 10 ADX mice killed 2 h after LPS injection. RNA for the "LPS/Dex" probe was from lungs of 12 ADX mice pretreated with 2 doses of Dex, and killed 2 h after LPS. RNA for the control probe was from lungs of Dex-treated ADX mice. Replicate filter lifts, cDNA probe synthesis, and hybridization were performed as described (59) .
For PCR, candidate phage were replated at low density. Inserts from well-separated progeny plaques were amplified using vector primers TAATACGACTCACTATAGGG and ATTAACCCTCACTAAAGGGA, or using primer pairs targeted to the EcoRI-SalI-XmaI and XhoI-NcoI-EagI adapter sequences.
Primers jDW (GTCGACTCCGGGCAGGT) and jDX (AGGTATCCATGGCCGAGGT) terminate at the junction between the subtracted cDNAs and the SSH adapters I and II, so Rsa I digestion of jDW, jDXamplified inserts removed all adapter-derived sequences from the ends of the cDNA. To amplify inserts lacking the Rsa I junction, such as those derived from cDNAs cut by Eag I or Xma I during the cloning process, the primers jE5 (GAATTCTCCAGCGTGTCGACT) and jE6 (TCGAGTGCTGTGTAGGTATCCAT) were used. Digestion of jE5, jE6-amplified inserts with Sal I and Nco I left 8-16 nt of adapter-derived sequences on the ends of the cDNAs. An annealing temperature of 60 C was used for all 3 primer pairs. The ends of vector primer-amplified cDNA inserts were sequenced using adapter primers jDW or jE5, and with jDX or jE6.
Analysis of candidate phage was performed in stages. First, inserts were amplified by PCR from 42 plaques (Group 1) that were •3 mm from the nearest neighbor on the low-density phage filter. To identify redundant phage within Group 1, replicate filter arrays of the phage inserts were hybridized with selected insert probes. Group 1 replicates among the remaining candidates were identified by hybridizing a replicate filter from the library screening with pooled Group 1 probes (after removal of adapter sequences). Among the 83 remaining candidates, the 32 Group 2 plaques were those whose nearest neighbor was • 1 mm distant, and for which the major plaque component could be identified unambiguously by PCR. The 35 candidates remaining after elimination of Group 2 replicates were plaque-purified by differential hybridization (Group 3).
Full-length cDNAs
A non-subtracted cDNA library in λ Zap II, prepared from lung RNA of LPS-treated ADX mice as described (71) , was screened by hybridization with the candidate LINCR insert. Potential full-length phage were converted to plasmid form and sequenced. IMAGE Consortium (37) clones for OASL-2 and human LINCR were obtained from Incyte Genomics (Palo Alto, CA).
Northern analysis and ribonuclease protection assay
Northern analysis of total cellular RNA, 10 µg/lane, was performed as described (51, 58) .
Autoradiographic signal intensities were quantitated by PhosphorImaging (Molecular Dynamics, Sunnyvale, CA). Corrections for lane-to-lane variations in loading were made using the signal intensity of the same filter reprobed with rpS2. We verified that LPS and dexamethasone did not affect lung expression of rpS2 message under the conditions used in this paper (51, 71) . Signal intensities for IFN-γ and IL-6 were determined by ribonuclease protection assay (MCK-1 probe set, BD Pharmingen, San Diego, CA, ) and corrected for loading variations using the rpL32 signal.
Sequence analysis and contig assembly were performed using MacVector and AssemblyLign (Accelrys, Inc., Madison, WI). Multiple alignment and phylogenetic analysis were performed using Clustal W (64) . Tree diagrams were drawn from the Clustal W output using TreeView (43) . The human LINCR cDNA was predicted from genomic sequences using the GENSCAN (12) and Fgenes (http://genomic.sanger.ac.uk/) programs. The positions of ubiquitin-like domains in the OASL proteins were determined by searching the NCBI conserved domain database (2).
Identification of candidate GARG cDNAs
To identify candidate GARG cDNAs, we constructed a subtracted library enriched in endotoxemia-induced genes, and then screened the library by differential hybridization. The subtraction was performed using the SSH technique (17, 18) , as described in Methods. The "tester"
and "driver" were Rsa I-digested cDNA populations prepared from lung RNA of LPS-treated and of Dex-treated ADX mice, respectively. The differential hybridization screening was performed by hybridizing replicate filter lifts of the subtracted library phage with (1) an "LPS" cDNA probe synthesized from lung RNA of ADX mice killed 2 h after i.v. injection of LPS, (2) an "LPS/Dex" probe from lung RNA of ADX mice pretreated with Dex and killed 2h after i.v. injection of LPS, and (3) a control cDNA probe from lung RNA of ADX mice treated with Dex. The criteria for selection of GARG candidate phage plaques were (1) increased signal density on the "LPS" filter compared to the control filter (induction during endotoxemia), and (2) decreased signal on the "LPS/Dex" filter compared to the "LPS" filter (glucocorticoid attenuation). More than 90% of the library clones screened satisfied the first criterion, verifying that the library was highly enriched in endotoxemia-induced genes. From a screening of 6600 plaques, we identified 599 candidate GARG phage satisfying both criteria (9% of the phage screened).
The candidate phage were analyzed in three stages (see Methods). The 42 Group 1 clones yielded cDNAs for 12 different genes, 10 of which were subsequently confirmed as GARGs by Northern analysis (below). The Group 2 and Group 3 clones yielded 19 and 24 additional genes, respectively, of which 13 in each group were confirmed as GARGs. In accordance with the expectation that the randomly picked Group 1 clones were likely to be those most abundant in the subtracted library, all had been cloned previously. There were two novel cDNAs (GBP-5 and LINCR) in Group 2, and two (I-TAC and OASL-2) in Group 3. Because of the method used to eliminate replicate phage, the abundances of clones for the cDNAs in Groups 1 and 2 were not determined. However, 11 of the 13 confirmed Group 3 GARGs were represented by a single clone.
The large proportion of single isolates among the Group 3 clones indicates that the screening was not exhaustive.
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Candidate gene expression in normal and adrenalectomized mice
To confirm the identification of GARG cDNAs, and eliminate false positives among the 55 final candidates, their expression characteristics were evaluated by Northern analysis. First, induction during endotoxemia and attenuation by dexamethasone of all candidates were evaluated in normal (non-operated) mice. Our criteria for a GARG message were (1) an endotoxemia-induced increase in lung message expression of 2-fold or more, and (2) attenuation by Dex of 25% or more of the endotoxemia-induced increase. Thirty-five of the 55 candidate cDNAs met both of these criteria in normal mice (Table I) .
Next, we evaluated the effect of adrenalectomy on the expression characteristics of the remaining candidates. We hoped that for some of these candidates, the absence of endogenous glucocorticoids in ADX mice would allow detection of attenuation by Dex, as we had previously observed for LIX (51) . A selection of candidates already confirmed as GARGs in normal mice were also studied in this second, independent experiment comparing normal, ADX, and shamadrenalectomized mice. First, the expression of LIX and the novel cDNA LINCR were evaluated using Northern blots containing individual RNA samples from all mice in each treatment group, Fig.   1A . While LIX expression in sham-operated and normal mice was similar, the endotoxemia-induced expression of LIX was 10.3-fold greater in ADX mice than the level expressed during endotoxemia in normal mice. Dexamethasone attenuated the LPS-induced expression in ADX mice to a level comparable to that of LPS-treated normal mice (with or without Dex), confirming the results of our previous study (51) . In contrast to LIX, endotoxemia-induced LINCR message was not increased in ADX as compared with normal and sham-operated mice, and was attenuated by Dex to a similar extent in all three groups of mice. The remaining candidates, and a number of the GARG cDNAs already identified, were evaluated using replicate Northern blots of pooled RNA samples, Table I and Fig. 1B .
All of the candidates tested that had met the criteria for GARGs in normal mice in the first experiment were confirmed as GARGs in both normal and ADX mice in this second, independent experiment. Only one additional candidate, P-selectin, was identified as glucocorticoid-attenuated in ADX mice but not normal mice, bringing the total of confirmed GARGs isolated in the screening to induced expression among GARGs. Adrenalectomy produced marked enhancement of LPS-induced expression of LIX (10-fold) and IL-6 (8-fold), and 2-fold or greater enhancement of LPS-induced expression of ICAM-1, P-selectin, IL-1β, MCP-1, MIP-1α, and IIGP. The ADX-enhanced LPSinduced expression of these genes was reduced by Dex to levels similar to those in LPS/Dex treated normal and sham-operated mice (Fig. 1) , which indicates that the enhancement of LPS-induced expression in ADX mice was due to loss of the endogenous glucocorticoid response, and not to other effects of adrenalectomy.
Characteristics of the GARG cDNAs
The 36 GARG cDNAs identified in this study include diverse categories of genes, Table I .
Although all were induced by LPS and attenuated by dexamethasone, they exhibited wide quantitative differences in responses to LPS and dexamethasone in normal mice, and qualitative differences in the effect of adrenalectomy. IFN-γ, IL-6, LIX, and MIG, previously identified as GARGs and included in Table I for comparison, were not among the 36 cDNAs identified in the screen. This provides a further indication that the screening was not exhaustive. Four of the cDNAs cloned in the GARG screening were new murine sequences: I-TAC, GBP-5, OASL-2, and LINCR.
Our results for murine I-TAC were reported previously (71) . The sequence features and expression characteristics of murine GBP-5, a new member of the guanylate binding protein family of large GTPases (46, 72), will be described separately (T. T. N. and J. B. S., manuscript in preparation). The complete cDNA sequences of OASL-2 and LINCR are described below.
Our screening focused on genes expressed in the lung, but was not designed to select lungspecific genes. Message expression of 15 GARGs was evaluated in brain, lung, heart, liver, spleen, kidney, small intestine, and skeletal muscle. Except for OASL-2 and LINCR (discussed below), expression levels were low or undetectable in all organs of control mice. All 15 GARGs evaluated were substantially induced in at least 2 other organs in addition to lung, and most were detectably induced in all organs examined (not shown). We conclude that most GARGs expressed in the lung during endotoxemia are not lung-specific.
Identification of a new oligoadenylate synthetase-like gene, murine OASL-2.
One of the Group 3 clones had an incomplete open reading frame with similarity to the   LCMP-00496-2001.R1, p. 13 human 2´-5´ Oligoadenylate Synthetase-Like (OASL) and murine M1204/OASL-p54 proteins (26, 49, 65) . We refer to M1204 and its presumed alternative splice form (GenBank AK010034) as murine OASL-1. To clarify the relationship of our partial cDNA to these genes, we searched the Fig. 1 ). The •2.5 kb message was expressed in the small intestine of control mice, and strongly induced during endotoxemia in the heart, liver, spleen, small intestine, and kidneys (not shown) as well as in lung (Fig. 1) .
The murine OASL-2 and human OASL proteins are highly similar throughout their lengths, 
Identification of a novel Neuralized-related RING domain protein, LINCR
The LINCR cDNA was represented by a single Group 2 candidate clone containing a 2078 nt insert with an incomplete open reading frame at the 5´ end. Northern blotting using the insert as a probe identified a single 2.8 kb band in lung RNA from LPS-treated mice. BLAST searching revealed no significant matches to known sequences. Four full-length LINCR clones were obtained by screening a non-subtracted library prepared from the same RNA used for the tester population of the subtracted library. Two clones were completely sequenced on both strands, and were identical except for a silent polymorphism at nt 105 of the 2588 nt consensus sequence, which includes a 15 nt poly-A tail. The LINCR sequence was assigned GenBank accession number AF321278. The Murine LINCR mRNA was strongly induced in the lung during endotoxemia, and attenuated by Dex (Table I and Fig. 1 ). These characteristics were essentially unaffected by adrenalectomy or sham operation. However, expression of LINCR in saline-treated ADX mice was 3-fold higher than in normal or sham-operated mice (Fig 1A) , indicating that basal lung expression of LINCR is sensitive to the levels of glucocorticoids normally circulating in unstressed mice. LINCR mRNA was also induced in heart and kidney, and was constitutively expressed in the small intestine (not shown). LINCR expression in the lung was evaluated 1, 2, 4, and 8 h following LPS injection, and in controls (3 mice per group). After a rapid rise to a peak at 1 h, LINCR expression remained high for 4 h, then decreased at 8 h to 50% of the initial peak value (not shown).
Identification of a predicted human LINCR homologue.
A translated BLAST search of the GenBank draft human genome sequence database using the murine LINCR protein sequence identified a closely related gene on human chromosome 2p11 This study focuses on the subset of genes whose induction in response to inflammatory stimuli is attenuated by glucocorticoids, which we refer to as glucocorticoid-attenuated response genes, or GARGs, to distinguish them from non-induced genes whose expression is reduced by glucocorticoids. Our underlying hypothesis is that GARG expression characteristics define a large subset of inflammation-related genes, and that identifying and determining the functions of GARGs participating in specific disease processes will reveal new targets for therapeutic intervention.
The results of this study, the first to attempt the systematic identification of GARGs in an in vivo model, indicate that genes with these regulatory characteristics are numerous and diverse. As expected, some of the 36 cDNAs cloned and verified as GARGs by Northern analysis in this study (Table I) The GARG cDNAs identified in this study represent diverse functional and structural categories of genes (Table I) . Half of these cDNAs were originally identified as interferon-inducible genes. These include the three members of the IFN-induced TPR domain family (p56 or IFI-56 family) cloned in our earlier GARG screening in 3T3 cells (13, 36, 57, 69) , and multiple members of the GBP and IRG-47 families of IFN-inducible GTP-binding proteins (8, 25, 46, 66) . It was recently demonstrated that the IRG-47 family member IGTP (Table I) is involved in host resistance to Toxoplasma gondii (24, 63) . Human GBP-1 and murine GBP-2 have recently been shown to
LCMP-00496-2001.R1, p. 18
modulate cell proliferation (22, 23) . The chemokines IP10 and MIG, which together with ITAC form a distinct subgroup of CXC chemokines (71) , were also originally cloned as IFN-inducible genes (19) . The fact that a high proportion of the genes identified in this study were originally described as interferon-inducible genes may reflect, in part, the role of IFN-γ release in endotoxemia. However, it may also be a reflection of the major efforts devoted to characterizing IFN-γ-induced genes (9, 15), many of which are also induced by LPS or other inflammatory cytokines.
We used adrenalectomized mice for our screening in order to eliminate the effects of endogenous glucocorticoids, and maximize potential message attenuation in response to an exogenous steroid. This choice was based on our previous studies of LIX, whose endotoxemiainduced expression in the lung and other tissues was glucocorticoid-attenuated in ADX but not normal mice (51) . In the present study, we found that all but one of the GARG cDNAs we identified were glucocorticoid-attenuated in normal as well as ADX mice (Table I) . However, significant enhancements of endotoxemia-induced expression were observed for several genes in addition to LIX, including IL-6, ICAM-1, P-selectin, IL-1β, MCP-1, MIP-1α, and IIGP (Table I) . ADX-induced enhancement of message expression has been described for IFN-γ, IL-1β, IL-6, and a few other cytokines in the spleen during murine cytomegalovirus infection (53) , and for IL-1β and IL-6 in spleens of LPS-treated rats (45, 55) . Interestingly, the LPS-induced expression of the IFN-γ induced chemokines MIG and I-TAC was reduced 40-50% in ADX as compared with normal and shamoperated mice (Table I and Fig. 1 ), while expression of the closely related IFN-γ induced chemokine IP10 was unaffected by adrenalectomy. The mechanisms responsible for these gene-specific effects of adrenalectomy have not been studied. Perhaps the genes showing the largest ADX-induced increases in LPS-induced expression are those most sensitive to attenuation by endogenous glucocorticoids at the levels induced during endotoxemia. Alternatively, the LPS-induced expression of specific genes might be affected by loss of adrenal catecholamines and increased norepinephrine secretion, or by other compensatory responses to adrenalectomy.
The idea of finding new potential targets for anti-inflammatory treatments by identifying genes with GARG regulatory characteristics is applicable to other inflammatory models, and is not limited to the specific techniques used in this study. Microarrays are now more widely available than at the time this study was initiated, and would likely be the method of choice for future studies.
Nevertheless, microarrays remain expensive and do not, as yet, provide true genome-wide coverage, so screening of subtracted libraries should continue to be valuable for certain applications. Some of the techniques developed for this study may be useful to other investigators. Although the subtracted cDNAs produced by the SSH procedure can be easily cloned into plasmid vectors, differential screening of λ phage is more sensitive and reproducible, in our experience (59) . Unfortunately, the standard SSH adapters do not include sites convenient for cloning into λ. Rather than alter the SSH adapters, which might have unpredictable effects on the efficiency of the suppression PCR (17), we designed adapters that facilitated both the cloning into λ Zap II and, by incorporating convenient restriction and primer sites, the downstream analysis of phage inserts. The approaches we used to identify phage inserts by PCR, and to eliminate redundant phage by hybridization, avoided repeated differential screenings for plaque purification and greatly reduced sequencing costs.
One of the cDNAs we cloned encoded a new oligoadenylate synthetase-like gene (26, 49, 65) , which we call murine OASL-2. The functions of the OASL genes are unknown, but the 2´-5´ oligoadenylate synthetases have a well-defined function in a regulated RNA decay pathway involved in the antiviral and growth inhibitory effects of interferons (30, 48, 56) . When activated by doublestranded RNA, the OAS enzymes catalyze the production of a mixture of 2´-5´ linked oligomers of adenylate (2-5A), whose only known function is to activate the latent ribonuclease RNase L. RNase L activation requires 2-5A oligomers containing 3 or more adenylates.
The OASL genes contain an N-terminal OAS-like domain plus two characteristic C-terminal ubiquitin-like domains not present in the OAS genes (Figs. 2 and 3A) . Intrinsic ubiquitin-like domains may participate in regulating the activity or stability of some proteins (26) , but the role of the ubiquitin-like domains in the OASL proteins has not been determined. The function of the OAS domain in the OASL proteins is uncertain also. Neither the p-59 and p-56 forms of human OASL had any detectable 2-5A synthetase activity (26, 49) . In contrast, murine OASL-1 (M1204 form) synthesized 2-5A dimers (incapable of activating RNase L) but not larger oligomers. The activity was not dependent on or enhanced by dsRNA, however. The protein we refer to as chicken OASL has OAS activity, and was originally described as chicken OAS (62, 73) . The sizes of the 2-5 A oligomers produced by chicken OAS/OASL and requirement for activation by dsRNA were not   LCMP-00496-2001.R1, p. 20 reported, however. From an evolutionary point of view, it will be very interesting to determine whether the chicken genome contains orthologues of the mammalian OAS genes (lacking ubiquitinlike domains) in addition to the OAS/OASL gene. If not, this would suggest that the mammalian OAS family evolved by gene duplication from an ancestral vertebrate OASL gene.
Phylogenetic analysis indicates that the OASL-2 protein is closely related to human OASL (Fig. 3B) . However, the expression patterns of these genes differ. We found that murine OASL-2 message was easily detected in the small intestine but not the spleen in control mice, and during endotoxemia was strongly induced in the lung, heart, liver, spleen, and kidneys (not shown). In contrast, expression of human OASL message in small intestine was low, with greater expression in spleen, peripheral blood leukocytes, and other tissues (26) . In cell lines, human OASL message was induced by IFN-α or IFN -γ (26, 49) . Murine OASL-1 (M1204), cloned from a murine spleen dendritic cell library, was expressed in thymus, bone marrow, and mature dendritic cells, but not in the other leukocytes tested, and was localized by in situ hybridization to dendritic cells in spleen and lung (65) . Future studies directly comparing the expression and regulation of murine OASL-1 and OASL-2 may provide useful clues about their functions.
The LINCR cDNA encodes a novel protein related to the Drosophila neuralized gene product, which is involved in Notch-pathway dependent cell fate decisions (34, 35, 75) . The Neur protein is localized primarily to the plasma membrane (34, 75) . It contains two copies of the distinctive neuralized repeat (NR) domain, plus a C-terminal C3HC4 RING domain (10, 47) . Recent studies have shown that the RING domains of Drosophila and Xenopus Neur have ubiquitin E3 ligase activity, and that at least one of the targets of ubiquitination by Neur is the Notch ligand Delta (16, 33, 44, 74) . Human and murine homologues of Drosophila neur have also been identified recently. Human Neur was cloned as potential tumor suppressor gene on chromosome 10 at a site frequently deleted in malignant astrocytomas (42) . Remarkably, the murine and human Neur proteins are 94% identical (52, 67) , suggesting that they serve a critical, highly conserved, function.
Murine LINCR and its predicted human homologue on chromosome 2 (Fig. 4) share a Cterminal RING domain similar to those in murine, human, and Drosophila Neur, and in C. elegans F10D7.5, but have only a single NR domain (Fig. 5) . Murine Neur was expressed in multiple tissues in the embryo but was detected in adults only in brain (52) , consistent with functions in development   LCMP-00496-2001.R1, p. 21 and the nervous system. In contrast, LINCR mRNA was expressed in the adult mouse small intestine, a tissue constantly exposed to inflammatory stimulation by luminal bacteria. LINCR expression was also induced in the lung during endotoxemia, and attenuated by Dex (Fig 1 and data not shown). LINCR's expression pattern and structural similarity to Neur suggest the hypothesis that it may act as an E3 ligase to target for degradation one or more components of signaling pathways involved in innate immune or cell differentiation responses.
The 36 cDNAs identified in this study probably represent only a fraction of the GARGs involved in the lung response to endotoxemia. We know that the differential screening was not exhaustive, because eleven of the 13 confirmed GARGs from the Group 3 candidate pool were single isolates. Furthermore, known GARGs including IFN-γ, IL-6, LIX, and MIG (Table I) were not identified in the screening, perhaps because their message expression was low at the 2-hour time point chosen for the differential screening. Injection of LPS is expected to trigger a cascade of immediate-early, early, and late gene induction, so we would expect to identify different sets of GARGs if the evaluation were performed at other time points. Taken together, our results suggest that future studies using microarrays or other techniques could identify many additional glucocorticoid-attenuated response genes whose functions and roles in lung inflammation are presently unknown. injection of LPS or saline, with or without Dex pretreatment as described in Methods, using pooled RNA samples (4 mice/group). GenBank accession numbers are in parentheses following the gene names. New cDNAs cloned in this screening project are indicated by asterisks.
b Induction factor is the ratio of LPS-induced message level to the level in saline-treated normal (non-operated) mice.
c Dex attenuation is the difference between expression levels in LPS-treated and LPS/Dex-treated mice, divided by the difference between expression levels in LPS-treated and saline-treated mice.
d ADX-LPS enhancement is the ratio of LPS-induced expression in ADX mice to LPS-induced expression in normal mice.
e Dashes indicate absent data for genes not studied in ADX mice. 
